BACKGROUND The benefits of erythropoiesis-stimulating agents (ESA) for dialysis patients have been demonstrated. However, it remains unclear whether the efficacy and safety of new, longer-acting ESA given less frequently is equivalent to recombinant human erythropoietin (rHuEPO) preparations. This is an update of a review first published in 2002 and last updated in 2005. OBJECTIVES This revie...

Background: Pharmaceutical interaction in US residencies is common. This study explores the extent and type of learner interactions family medicine with pharmaceutical industry compares from 2008, 2013, 2019. Methods: We surveyed program directors 628 8 questions using 2019 Council Academic Family Medicine Educational Research Alliance Survey compared responses to 2008 2013 re...